State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, China.
Ophthalmologic Center, Affiliated Kashi Hospital of Sun Yat-sen University, First People's Hospital of Kashi Prefecture, Kashi, 844000, China.
Lasers Med Sci. 2023 Feb 18;38(1):75. doi: 10.1007/s10103-023-03735-z.
The objective of this study was to evaluate the efficacy and safety of super pulse CO laser-assisted punctoplasty with canalicular curettage in primary canaliculitis. In this retrospective serial case study, the clinical data of 26 patients who underwent super pulse CO laser-assisted punctoplasty for the treatment of canaliculitis were collected from January 2020 to May 2022. The clinical presentation, intraoperative and microbiologic findings, surgical pain severity, postoperative outcome, and complications were studied. Of the 26 patients, most were females (female:male 20:6), with a mean age of 60.1 ± 16.1 years (range, 19-93). Mucopurulent discharge (96.2%), eyelid redness and swelling (53.8%), and epiphora (38.5%) were the most common presentations. During the surgery, concretions were present in 73.1% (19/26) of the patients. The surgical pain severity scores ranged from 1 to 5, according to the visual analog scale, with a mean score of 3.2 ± 0.8. This procedure resulted in complete resolution in 22 (84.6%) patients and significant improvement in 2 (7.7%) patients, and 2 (7.7%) patients required additional lacrimal surgery with a mean follow-up time of 10.9 ± 3.7 months. The surgical procedure of super pulse CO laser-assisted punctoplasty followed by curettage appears to be a safe, effective, minimally invasive, and well-tolerated treatment for primary canaliculitis.
本研究旨在评估超脉冲 CO2 激光辅助泪小管切开术联合泪小管刮除术治疗原发性泪小管炎的疗效和安全性。在这项回顾性系列病例研究中，收集了 2020 年 1 月至 2022 年 5 月期间 26 例行超脉冲 CO2 激光辅助泪小管切开术治疗泪小管炎患者的临床资料。研究内容包括临床表现、术中及微生物学检查、手术疼痛严重程度、术后结果和并发症。26 例患者中，女性居多（女：男 20：6），平均年龄 60.1±16.1 岁（1993 岁）。最常见的表现为脓性分泌物（96.2%）、眼睑红肿（53.8%）和溢泪（38.5%）。术中 73.1%（19/26）的患者存在结石。手术疼痛严重程度评分采用视觉模拟评分法，范围为 15 分，平均 3.2±0.8 分。22 例（84.6%）患者完全缓解，2 例（7.7%）患者显著改善，2 例（7.7%）患者需要额外行泪道手术，平均随访时间为 10.9±3.7 个月。超脉冲 CO2 激光辅助泪小管切开术联合刮除术治疗原发性泪小管炎，是一种安全、有效、微创且耐受性良好的治疗方法。
